1. Home
  2. AVTR vs EXAS Comparison

AVTR vs EXAS Comparison

Compare AVTR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avantor Inc.

AVTR

Avantor Inc.

HOLD

Current Price

$11.19

Market Cap

8.5B

Sector

Industrials

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.58

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVTR
EXAS
Founded
1904
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
11.0B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
AVTR
EXAS
Price
$11.19
$101.58
Analyst Decision
Buy
Buy
Analyst Count
13
20
Target Price
$15.31
$77.94
AVG Volume (30 Days)
8.4M
10.8M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,575,200,000.00
$3,082,033,000.00
Revenue This Year
N/A
$19.40
Revenue Next Year
$0.17
$13.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.47
52 Week Low
$10.62
$38.81
52 Week High
$23.32
$101.95

Technical Indicators

Market Signals
Indicator
AVTR
EXAS
Relative Strength Index (RSI) 43.45 89.65
Support Level $10.86 $100.95
Resistance Level $11.57 $101.95
Average True Range (ATR) 0.35 0.35
MACD 0.06 -0.87
Stochastic Oscillator 40.94 61.17

Price Performance

Historical Comparison
AVTR
EXAS

About AVTR Avantor Inc.

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: